![Ulf Carl Magnus Boberg](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ulf Carl Magnus Boberg
Directeur Général chez
CREATIVE ANTIBIOTICS SWEDEN AB
Profil
Ulf Carl Magnus Boberg is currently the Chief Executive Officer & Head-Investor Relations at Creative Antibiotics AB since 2012.
Previously, he served as the Chief Executive Officer at Miris Holding AB from 2014 to 2016.
He has also held positions as the Chief Executive Officer at Global Genomics AB, Director at SpectraCure AB and NeoDynamics AB, and SVP-Clinical & Business Development at Affibody AB. Additionally, Dr. Boberg has worked as the Head-Medical Research at Gambro, Inc. and as the Vice President-Research & Development at AstraZeneca AB. He started his career as an Investment Manager at CareDx International AB. Dr. Boberg holds an MBA and a doctorate from the University of Uppsala.
Postes actifs de Ulf Carl Magnus Boberg
| Sociétés | Poste | Début |
|---|---|---|
| CREATIVE ANTIBIOTICS SWEDEN AB | Directeur Général | 18/05/2010 |
Anciens postes connus de Ulf Carl Magnus Boberg
| Sociétés | Poste | Fin |
|---|---|---|
| MIRIS HOLDING AB | Directeur Général | 04/10/2016 |
Global Genomics AB
 Global Genomics AB Miscellaneous Commercial ServicesCommercial Services Discovers disease genes, drug targets and disease-associated biomarkers | President | 30/11/2005 |
| NEOS AB | Directeur/Membre du Conseil | - |
| SPECTRACURE AB | Directeur/Membre du Conseil | - |
| ALLENEX AB | Directeur en chef des Investissements | - |
Formation de Ulf Carl Magnus Boberg
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
8
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Creative Antibiotics AB
 Creative Antibiotics AB Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Miris Holding AB
 Miris Holding AB Electronic Equipment/InstrumentsElectronic Technology Produces and markets analytical instruments for analyzing fluids | Electronic Technology |
Affibody AB
 Affibody AB BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops radioligand therapies for cancer treatment | Health Technology |
Gambro, Inc.
 Gambro, Inc. Medical/Nursing ServicesHealth Services Provides medical technology and healthcare services | Health Services |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services Researches and develops pharmaceutical products | Commercial Services |
CareDx International AB
 CareDx International AB Medical DistributorsDistribution Services Wholesales medical equipment and pharmacy goods | Distribution Services |
University of Uppsala
 University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Global Genomics AB
Global Genomics AB Miscellaneous Commercial ServicesCommercial Services Discovers disease genes, drug targets and disease-associated biomarkers | Commercial Services |
SpectraCure AB
 SpectraCure AB Electronic Equipment/InstrumentsElectronic Technology Develops and provides equipment for cancer treatment | Electronic Technology |
NeoDynamics AB
 NeoDynamics AB Medical SpecialtiesHealth Technology Develops equipment for diagnosis of breast cancer | Health Technology |
